Joseph J Manning Form 3 ABBOTT LABORATORIES / JOSEPH J MANNING ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

MANNING JOSEPH J

(Last) (First) (Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK IL 60064

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/16/2017

3. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Senior Vice President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common shares without par value	20,492	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)(1)	02/16/2008	02/15/2017	Common shares	100	25.2461	D
Option (right to buy)(1)	02/16/2009	02/15/2017	Common shares	100	25.2461	D
Option (right to buy)(1)	02/16/2010	02/15/2017	Common shares	100	25.2461	D
Option (right to buy)(1)	02/15/2009	02/14/2018	Common shares	1,067	26.6973	D
Option (right to buy)(1)	02/15/2010	02/14/2018	Common shares	1,067	26.6973	D
Option (right to buy)(1)	02/15/2011	02/14/2018	Common shares	1,066	26.6973	D
Option (right to buy)(2)	02/20/2016	02/19/2025	Common shares	15,742	47	D
Option (right to buy)(2)	02/20/2017	02/19/2025	Common shares	15,742	47	D
Option (right to buy)(2)	02/20/2018	02/19/2025	Common shares	15,742	47	D
Option (right to buy)(2)	02/19/2017	02/18/2026	Common shares	25,000	38.4	D
Option (right to buy)(2)	02/19/2018	02/18/2026	Common shares	25,000	38.4	D
Option (right to buy)(2)	02/19/2019	02/18/2026	Common shares	25,000	38.4	D

Explanation of Responses:

1. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

2. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

	John A. Berry, by power of attorney for Joseph J. Manning	01/25/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.